Intraoperative Superb Microvascular Imaging (SMI) with contrast agent of ultrasonography
EANS Academy. Ishikawa M. 09/27/19; 276122; EP12060
Dr. Mami Ishikawa
Dr. Mami Ishikawa

Access to this content is reserved for EANS members and attendees of this event. Click here to become an EANS member and gain your access to the full content of the EANS Academy

Discussion Forum (0)
Rate & Comment (0)
Objective: We reported the usefulness of intraoperative ultrasonography (US) with the Superb Microvascular Imaging (SMI) technique to detect low flow components. We combined this SMI technique with contrast agent technique and applied this US imaging for neurosurgery to distinguish tumor or hematoma from brain and to examine blood flow in moyamoya disease.
Methods: Twenty patients with brain tumor, 7 patients with ICH and 2 patients with moyamoya disease underwent operation under US monitoring using Aplio US system combining the SMI and contrast agent techniques. Features of the SMI include
(1) visualization of low-velocity flow with minimal motion artifact,
(2) high resolution of images, and
(3) high frame rates.
We calculated appearance time of contrast agent and vessel density in tumor and brain. In a hemorrhage onset type patient with moyamoya disease, US monitoring showed flow from lateral ventricle vessel to cerebral surface, and we analyzed lateral ventricle vessels of hemorrhage onset type patients (n=14) with original images of magnetic resonance angiography to compare to infarction onset type patients with moyamoya disease (n=22) and patients with unruptured aneurysm (n=20).
Results: Vessel flow was clearly visualized by the SMI and contrast agent techniques. Appearance time of contrast agent was decreased and vessel density was increased in tumor significantly, compared to brain. In hemorrhage onset type patients with moyamoya disease, arteries in lateral ventricles were increased significantly. In ICH patients, we could find hematoma as avascular area with the US monitoring.
Conclusion: Intraoperative US monitoring using the SMI and contrast agent techniques produced pioneering images to recognize cerebral and tumor vessels and recognize avascular area in hemorrhage patienets. Asymptomatic patients with moyamoya disease may be hemorrhage onset type, when the patients have some arteries in lateral ventricles judging from the original images of the magnetic resonance angiography.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings